VIVEVE MED INC
VIVE
VIVE was delisted on the 18th of January, 2023.
30 hedge funds and large institutions have $26M invested in VIVEVE MED INC in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 14 closing their positions.
12% less capital invested
Capital invested by funds: $29.6M → $26M (-$3.56M)
25% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 8
27% less funds holding
Funds holding: 41 → 30 (-11)
79% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 14
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Top Buyers
Top Sellers
VIVE Hedge Fund Activity: Q1 2019 in Review
30 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in VIVEVE MED INC (VIVE) for Q1 2019, worth a combined $26M — down 12% from $29.6M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of VIVE and 3 opened new positions — a net loss of 11 holders — while 8 trimmed existing stakes and 6 added.
The largest buyer was Meitav Investment House, adding an estimated $243K. The largest seller was Hood River Capital Management, cutting an estimated $387K.
- 30 institutional investors held VIVEVE MED INC (VIVE) as of Q1 2019, down from 41 in Q4 2018.
- Funds reported $26M of VIVEVE MED INC stock for Q1 2019, down 12% quarter-over-quarter.
- 3 funds opened new VIVEVE MED INC positions in Q1 2019 and 14 closed out, a net change of -11 holders.
- The largest VIVEVE MED INC buyer in Q1 2019 was Meitav Investment House, an estimated $243K added.
- The largest VIVEVE MED INC seller in Q1 2019 was Hood River Capital Management, an estimated $387K sold.
Based on aggregated 13F filings for Q1 2019.